Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P H Groot

Showing results (41-50 of 58) with videos related to

Pageof 6
Sort By:
The Biochemical Journal|October 1, 1996
Time-course studies by synchrotron X-ray solution scattering of the structure of human low-density lipoprotein during Cu(2+)-induced oxidation in relation to changes in lipid compositionD F Meyer, A S Nealis, C H Macphee, et al.
Biochemical Pharmacology|February 5, 2000
Selective binding of the truncated form of the chemokine CKbeta8 (25-99) to CC chemokine receptor 1(CCR1)T A Berkhout, J Gohil, P Gonzalez, et al.
Journal of Medicinal Chemistry|December 25, 1992
ATP-citrate lyase as a target for hypolipidemic intervention. Sulfoximine and 3-hydroxy-beta-lactam containing analogues of citric acid as potential tight-binding inhibitorsR E Dolle, D McNair, M J Hughes, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|January 15, 2000
Effect of macrophage-derived mouse ApoE, human ApoE3-Leiden, and human ApoE2 (Arg158-->Cys) on cholesterol levels and atherosclerosis in ApoE-deficient miceM Van Eck, N Herijgers, K W Van Dijk, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|December 16, 2000
Effect of human scavenger receptor class A overexpression in bone marrow-derived cells on cholesterol levels and atherosclerosis in ApoE-deficient miceM Van Eck, M P De Winther, N Herijgers, et al.
Bioorganic & Medicinal Chemistry Letters|August 22, 2001
Conformationally restricted indolopiperidine derivatives as potent CCR2B receptor antagonistsJ Witherington, V Bordas, D G Cooper, et al.
Atherosclerosis|September 23, 1997
SR-12813 lowers plasma cholesterol in beagle dogs by decreasing cholesterol biosynthesisT A Berkhout, H M Simon, B Jackson, et al.
European Journal of Biochemistry|March 1, 1992
Cloning and expression of a human ATP-citrate lyase cDNAN A Elshourbagy, J C Near, P J Kmetz, et al.
The Biochemical Journal|August 7, 1998
The role of ATP citrate-lyase in the metabolic regulation of plasma lipids. Hypolipidaemic effects of SB-204990, a lactone prodrug of the potent ATP citrate-lyase inhibitor SB-201076N J Pearce, J W Yates, T A Berkhout, et al.
Arteriosclerosis and Thrombosis : a Journal of Vascular Biology|May 1, 1991
Postprandial lipoprotein metabolism in normolipidemic men with and without coronary artery diseaseP H Groot, W A van Stiphout, X H Krauss, et al.
Pageof 6

Showing results (41-50 of 58) with videos related to

Sort By:
Pageof 6
The Biochemical Journal|October 1, 1996
Time-course studies by synchrotron X-ray solution scattering of the structure of human low-density lipoprotein during Cu(2+)-induced oxidation in relation to changes in lipid compositionD F Meyer, A S Nealis, C H Macphee, et al.
Biochemical Pharmacology|February 5, 2000
Selective binding of the truncated form of the chemokine CKbeta8 (25-99) to CC chemokine receptor 1(CCR1)T A Berkhout, J Gohil, P Gonzalez, et al.
Journal of Medicinal Chemistry|December 25, 1992
ATP-citrate lyase as a target for hypolipidemic intervention. Sulfoximine and 3-hydroxy-beta-lactam containing analogues of citric acid as potential tight-binding inhibitorsR E Dolle, D McNair, M J Hughes, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|January 15, 2000
Effect of macrophage-derived mouse ApoE, human ApoE3-Leiden, and human ApoE2 (Arg158-->Cys) on cholesterol levels and atherosclerosis in ApoE-deficient miceM Van Eck, N Herijgers, K W Van Dijk, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|December 16, 2000
Effect of human scavenger receptor class A overexpression in bone marrow-derived cells on cholesterol levels and atherosclerosis in ApoE-deficient miceM Van Eck, M P De Winther, N Herijgers, et al.
Bioorganic & Medicinal Chemistry Letters|August 22, 2001
Conformationally restricted indolopiperidine derivatives as potent CCR2B receptor antagonistsJ Witherington, V Bordas, D G Cooper, et al.
Atherosclerosis|September 23, 1997
SR-12813 lowers plasma cholesterol in beagle dogs by decreasing cholesterol biosynthesisT A Berkhout, H M Simon, B Jackson, et al.
European Journal of Biochemistry|March 1, 1992
Cloning and expression of a human ATP-citrate lyase cDNAN A Elshourbagy, J C Near, P J Kmetz, et al.
The Biochemical Journal|August 7, 1998
The role of ATP citrate-lyase in the metabolic regulation of plasma lipids. Hypolipidaemic effects of SB-204990, a lactone prodrug of the potent ATP citrate-lyase inhibitor SB-201076N J Pearce, J W Yates, T A Berkhout, et al.
Arteriosclerosis and Thrombosis : a Journal of Vascular Biology|May 1, 1991
Postprandial lipoprotein metabolism in normolipidemic men with and without coronary artery diseaseP H Groot, W A van Stiphout, X H Krauss, et al.
Pageof 6